News
19h
Live Science on MSN2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
New vaccines are often evaluated in trials in which some participants receive a placebo. But not all studies can be designed ...
Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust ...
RNA-1083 vaccine is noninferior and induces higher immune responses than recommended influenza and COVID-19 vaccines against several influenza strains and severe acute respiratory syndrome coronavirus ...
There also was no link between miscarriage risk and the number of vaccinations a woman had gotten, or whether she’d gotten ...
While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the ...
The FDA also requested Novavax conduct a phase 4 study in patients aged 50 to 64 years without high-risk conditions for severe COVID-19.
6d
Green Matters on MSNCOVID-19 Vaccine Deemed Safe Long Term in New Study, Most Common Side Effects RevealedA half-decade since the pandemic, countless individuals and families have been left wondering: what is the long-term safety ...
During an interview in late April with Dr. Phil, Robert F. Kennedy Jr. reiterated his appeal to parents on vaccine safety: ...
Novavax today announced that the US Food and Drug Administration (FDA) has approved full licensure for its COVID-19 vaccine, ...
COVID, sparking debate about 'immunity debt.' Experts suggest that COVID-19 safety measures, while effective against the ...
A new study links growing vaccine skepticism to pet care. Lollypop Farm offers free rabies shots, food and vet access for dogs and cats in Rochester.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results